Skip to content

Evaluation of the effect of Laser in Fatty liver

Effectiveness of low-level laser in patients with Grade 2 and 3 fatty liver with increased liver enzymes

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20111121008146N18
Enrollment
60
Registered
2018-01-08
Start date
2017-09-23
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fatty liver grade 2 and 3 with increased liver enzymes. Liver disorders in diseases classified elsewhere

Interventions

Intervention 1: Intervention group: Low-level laser therapy with a wavelength of 830 nm, a power of 35 mW, on four points (right upper, right lower, upper left, lower left of liver or four lobes of th
Treatment - Devices
Placebo
Intervention group: Low-level laser therapy with a wavelength of 830 nm, a power of 35 mW, on four points (right upper, right lower, upper left, lower left of liver or four lobes of the liver) with di
Control group: Sham laser (silent laser) is used for blindness at the same points as desired. All variables, including the duration of radiation and the number of treatment sessions in the control gro

Sponsors

Shahid Beheshti University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
30 Years to 50 Years

Inclusion criteria

Inclusion criteria: Fatty liver grade2 and 3 with increased liver enzymes Age 30 to 50 years Complete satisfaction to participate in the study and completion of the therapeutic and follow up process

Exclusion criteria

Exclusion criteria: Diabetes Pregnant and lactating Metabolic syndrome Hyperlipidemia and hypercholesterolemia Age under 30 and over 50 years Taking any medication in a recent month hepatitis Cardiovascular patients Hypertension Hyperthyroidism and Hypothyroidism Fibroma and polycystic ovaries Hormonal disorders

Design outcomes

Primary

MeasureTime frame
Liver Enzyme Test. Timepoint: Before the intervention, the fourth session of the intervention and one month after the end of the intervention. Method of measurement: Laboratory tests.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Maryam Barati

Shahid Beheshti University of Medical Sciences

laser.cntr@yahoo.com+98 21 2274 9221

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026